Reducing brain Aβ burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 miceBIOMEDICINE & PHARMACOTHERAPYIF7.52024-04-010OAAI
Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signalingCELL DEATH & DISEASEIF9.62022-04-119OAAI
Non-genomic rewiring of vitamin D receptor to p53 as a key to Alzheimer's diseaseAGING CELLIF7.12021-11-027OAAI
A high-sucrose diet aggravates Alzheimer's disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 miceNEUROBIOLOGY OF AGINGIF3.52020-06-0138OAAI
Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activityJOURNAL OF NEUROINFLAMMATIONIF10.12019-06-0817OAAI
Apoptosis pathway CASP10 gene associated with methadone dose and interacted with GRK5EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72016-10-010PREAI
Identifying N-linked glycan moiety and motifs in the cysteine-rich domain critical for N-glycosylation and intracellular trafficking of SR-AI and MARCOJOURNAL OF BIOMEDICAL SCIENCEIF12.12016-02-1810OAAI
Impaired cognition and cerebral glucose regulation are associated with astrocyte activation in the parenchyma of metabolically stressed APPswe/PS1dE9 miceNEUROBIOLOGY OF AGINGIF3.52015-11-0132PREAI
Aryl Hydrocarbon Receptor Mediates Both Proinflammatory and Anti-Inflammatory Effects in Lipopolysaccharide-Activated MicrogliaGLIAIF5.12015-02-1796PREAI
Cysteine-rich domain of scavenger receptor AI modulates the efficacy of surface targeting and mediates oligomeric Aβ internalizationJOURNAL OF BIOMEDICAL SCIENCEIF12.12013-08-0216OAAI
Curcumin Attenuates the Expression and Secretion of RANTES after Spinal Cord Injury In Vivo and Lipopolysaccharide-Induced Astrocyte Reactivation In VitroJOURNAL OF NEUROTRAUMAIF3.82011-07-0149PREAI
Mechanism mediating oligomeric Aβ clearance by naive primary microgliaNEUROBIOLOGY OF DISEASEIF5.62011-06-01127PREAI
The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial ActivationMOLECULESIF4.62011-05-171OAAI
Neuroimmune Pharmacology of Neurodegenerative and Mental DiseasesJOURNAL OF NEUROIMMUNE PHARMACOLOGYIF3.52010-09-0715PREAI
Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease操纵小胶质细胞活化作为阿尔茨海默氏病的治疗策略CURRENT MEDICINAL CHEMISTRYIF3.52007-11-0130PREAI
Therapeutic strategy at the crossroad of neuroinflammation and oxidative stress in age-related neurodegenerative diseasesEXPERT OPINION ON THERAPEUTIC PATENTSIF4.62007-04-192PREAI
Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragmentNEUROBIOLOGY OF DISEASEIF5.62007-02-0142PREAI
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synucleinJOURNAL OF NEUROINFLAMMATIONIF10.12007-01-04123OAAI
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityGLIAIF5.12005-05-26113PRE
LPS-induced neuronal damage is prevented by nonsteroidal anti-inflammatory drugs and by genetic deletion of INOS and EP2NEUROBIOLOGY OF AGINGIF3.52004-07-010PREAI